EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism‐informed machine learning for individualized tacrolimus dose adjustment in the early post‐kidney transplant period

Hui Yu iD, Zihan Qin, Logan S Smith, Jeong M Park, Hao-Jie Zhu

British Journal of Clinical Pharmacology · 2026

DOI: 10.1002/bcp.70448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Hui Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA. Hauptthemen laut MEDLINE: Tacrolimus, Kidney Transplantation, Immunosuppressive Agents, Machine Learning. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Stimulus Award from the University of Michigan College of Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Tacrolimus dosing in the early post‐kidney transplant period is challenging due to a narrow therapeutic index and substantial interindividual pharmacokinetic (PK) variability. This study aimed to develop and validate mechanism‐informed machine learning (ML) models to support individualized tacrolimus dosing during this critical period.

Methods

A total of 4311 tacrolimus trough concentrations (C trough ) within 7 days post‐transplant were obtained from 1624 kidney transplant recipients. Two ML models, Gated Recurrent Unit (GRU) and eXtreme Gradient Boosting (XGBoost), were developed to predict C trough and recommend doses to achieve target levels. Both models incorporated PK principles based on linear pharmacokinetics. Model performance was compared to a traditional Bayesian population PK (PopPK) model and purely data‐driven ML models via internal cross‐validation and external validation.

Results

The mechanism‐informed GRU model outperformed the Bayesian PopPK model in both internal validation (MSE = 7.81 vs . 9.27 ng 2 /mL 2 , R 2 = 0.537 vs . 0.450) and external validation (MSE = 6.09 vs . 8.96 ng 2 /mL 2 , R 2 = 0.397 vs . 0.211). The mechanism‐informed XGBoost model performed comparably to the GRU model. The incorporation of PK principles enhanced model interpretability and generalizability without reducing accuracy. When clinically administered doses, determined by conventional therapeutic drug monitoring, fell within the GRU model's recommended range, subsequent C trough reached the therapeutic target (8–12 ng/mL) in 51.3% of cases, compared to 37.0% overall (p < 0.01).

Conclusion

Mechanism‐informed ML models offer a robust and interpretable approach for individualized tacrolimus dosing, with the potential to improve therapeutic target attainment by enabling accurate dose adjustments in the early post‐transplant period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TacrolimusKidney TransplantationImmunosuppressive AgentsMachine LearningHumansBayes TheoremFemaleBoosting Machine Learning AlgorithmsMalePredictive Learning ModelsMiddle AgedModels, BiologicalAdultDose-Response Relationship, DrugPrecision MedicinePrediction AlgorithmsGraft RejectionDrug Monitoring

Stichwörter der Autor:innen

kidney transplantationmachine learningpharmacokineticsprecision dosingtacrolimus

Substanzen

TacrolimusImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Department of Clinical Pharmacy, University of Michigan, Ann Arbor, MI, 48109, USA.

ORCID-Profile: Hui Yu

Förderung

  • Research Stimulus Award from the University of Michigan College of Pharmacy

Zitieren

APA

Yu, H., Qin, Z., Smith, L. S., Park, J. M., & Zhu, H. J. (2026). Mechanism‐informed machine learning for individualized tacrolimus dose adjustment in the early post‐kidney transplant period. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70448

Vancouver

Yu H, Qin Z, Smith LS, Park JM, Zhu HJ. Mechanism‐informed machine learning for individualized tacrolimus dose adjustment in the early post‐kidney transplant period. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70448

BibTeX
@article{Yu2026,
  author = {Yu, Hui and Qin, Zihan and Smith, Logan S and Park, Jeong M and Zhu, Hao-Jie},
  title = {Mechanism‐informed machine learning for individualized tacrolimus dose adjustment in the early post‐kidney transplant period},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  doi = {10.1002/bcp.70448}
}
Kostenlos starten →